Compare DUOT & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOT | CNXU |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.2M | 215.9M |
| IPO Year | 2017 | 2025 |
| Metric | DUOT | CNXU |
|---|---|---|
| Price | $8.86 | $4.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 685.0K | 209.5K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.96 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $27,023,651.00 | N/A |
| Revenue This Year | $50.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.24 | ★ N/A |
| Revenue Growth | ★ 271.16 | N/A |
| 52 Week Low | $6.17 | $4.19 |
| 52 Week High | $15.28 | $13.66 |
| Indicator | DUOT | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 38.27 |
| Support Level | $8.04 | $4.19 |
| Resistance Level | $9.52 | $10.41 |
| Average True Range (ATR) | 0.36 | 0.57 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 76.23 | 21.90 |
Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.